1. Home
  2. RXT vs ACIU Comparison

RXT vs ACIU Comparison

Compare RXT & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$0.98

Market Cap

250.9M

Sector

Technology

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.21

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXT
ACIU
Founded
1998
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
250.9M
213.3M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
RXT
ACIU
Price
$0.98
$3.21
Analyst Decision
Hold
Strong Buy
Analyst Count
6
2
Target Price
$1.61
$10.00
AVG Volume (30 Days)
1.3M
1.4M
Earning Date
02-19-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,688,500,000.00
$5,482,957.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.63
$644.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.96
$1.43
52 Week High
$3.03
$4.00

Technical Indicators

Market Signals
Indicator
RXT
ACIU
Relative Strength Index (RSI) 36.93 54.48
Support Level $0.96 $3.02
Resistance Level $1.01 $3.30
Average True Range (ATR) 0.05 0.23
MACD 0.00 0.02
Stochastic Oscillator 5.42 35.48

Price Performance

Historical Comparison
RXT
ACIU

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: